ID
23275
Description
Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00147745
Link
https://clinicaltrials.gov/show/NCT00147745
Keywords
Versions (1)
- 7/1/17 7/1/17 -
Uploaded on
July 1, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 2 Diabetes NCT00147745
Eligibility Type 2 Diabetes NCT00147745
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Lipid-lowering therapy Dosage Change | Antihypertensive Agents Dosage Change
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0585943
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0392747
- UMLS CUI [2,1]
- C0003364
- UMLS CUI [2,2]
- C0178602
- UMLS CUI [2,3]
- C0392747
Description
colesevelam | Hyperlipidemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0541155
- UMLS CUI [2]
- C0020473
Description
Serum Triglyceride Measurement
Data type
boolean
Alias
- UMLS CUI [1]
- C0542495
Description
Low density lipoprotein cholesterol measurement
Data type
boolean
Alias
- UMLS CUI [1]
- C0202117
Similar models
Eligibility Type 2 Diabetes NCT00147745
- StudyEvent: Eligibility
C0038766 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C0205394 (UMLS CUI [3,2])
C1272691 (UMLS CUI [3,3])
C0028754 (UMLS CUI [2])
C1305855 (UMLS CUI [3])
C0178602 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])
C0003364 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
C0020473 (UMLS CUI [2])